51 cases on record
- Cases on record
- 51
- As claimant
- 3
- As respondent
- 48
- Patents held
- Not recorded
- Core tech
- Not recorded
| Case no. | Parties | Role | Court | Filed | Duration | Outcome |
|---|---|---|---|---|---|---|
| 2:26-cv-02036 | Ars Pharmaceuticals Operations, Inc. v. Lupin Limited | Defendant | D.N.J. | 26 Feb 2026 | 60 d | Case Consolidated |
| 2:25-cv-17843 | Oyster Point Pharma, Inc. v. Lupin Limited | Defendant | D.N.J. | 21 Nov 2025 | 187 d | Case Dismissed |
| 3:25-cv-13779 | Astellas Pharma, Inc. v. Lupin Limited | Defendant | D.N.J. | 25 Jul 2025 | 199 d | Closed |
| 1:25-cv-00578 | Novartis, AG v. Lupin Limited | Defendant | D. Del. | 9 May 2025 | 207 d | Voluntary dismissal |
| 2:25-cv-02860 | Aragon Pharmaceuticals, Inc. v. Lupin Limited | Defendant | D.N.J. | 18 Apr 2025 | 110 d | Voluntary dismissal |
| 1:25-cv-00349 | Bayer AG v. Lupin Limited | Defendant | D. Del. | 20 Mar 2025 | 264 d | Voluntary dismissal |
| 25-1239 | Lupin Limited v. Exeltis USA, Inc. | Plaintiff | Fed. Cir. | 3 Dec 2024 | 300 d | Case Remanded |
| 1:24-cv-01068 | Astellas Pharma, Inc. v. Lupin Limited | Defendant | D. Del. | 24 Sep 2024 | 513 d | Closed |
| 1:24-cv-01045 | Novartis, AG v. Lupin Limited | Defendant | D. Del. | 18 Sep 2024 | 69 d | Dismissed without Prejudice |
| 24-2297 | Otsuka Pharmaceutical Co., Ltd. v. Lupin Limited | Defendant | Fed. Cir. | 10 Sep 2024 | 618 d | Appeal Dismissed |
| 2:24-cv-08786 | Jazz Pharmaceuticals Ireland Limited v. Lupin Limited | Defendant | D.N.J. | 27 Aug 2024 | 99 d | Case Consolidated |
| 1:24-cv-00939 | Astellas Pharma, Inc. v. Lupin Limited | Defendant | D. Del. | 13 Aug 2024 | 555 d | Closed |
| 1:24-cv-00732 | Exeltis USA, Inc. v. Lupin Limited | Defendant | D. Del. | 20 Jun 2024 | 435 d | Dismissed with Prejudice |
| 24-1766 | Astellas Pharma, Inc. v. Lupin Limited | Defendant | Fed. Cir. | 1 May 2024 | 35 d | Voluntary dismissal |
| 24-1664 | Galdermalaboratories, L.P v. Lupin, Inc. | Defendant | Fed. Cir. | 8 Apr 2024 | 242 d | Appeal Dismissed |
| 1:24-cv-00138 | Bayer AG v. Lupin Limited | Defendant | D. Del. | 2 Feb 2024 | 686 d | Dismissed with Prejudice |
| 1:23-cv-01189 | ZS Pharma, Inc. v. Lupin Limited | Defendant | D. Del. | 20 Oct 2023 | 222 d | Consent Judgment |
| 1:23-cv-00964 | Amicus Therapeutics US, LLC v. Lupin Limited | Defendant | D. Del. | 1 Sep 2023 | 843 d | Consent Judgment |
| 1:23-cv-00819 | Astellas Pharma, Inc. v. Lupin Limited | Defendant | D. Del. | 28 Jul 2023 | 937 d | Closed |
| 1:23-cv-04027 | Novo Nordisk A/S v. Lupin Limited | Defendant | D.N.J. | 27 Jul 2023 | 235 d | Dismissed without Prejudice |
| 1:23-cv-04031 | Novo Nordisk A/S v. Lupin Limited | Defendant | D.N.J. | 27 Jul 2023 | 259 d | Dismissed without Prejudice |
| 2:23-cv-04027 | Novo Nordisk, Inc. v. Lupin, Ltd. | Defendant | D.N.J. | 27 Jul 2023 | 169 d | Case Transferred |
| 3:23-cv-04027 | Novo Nordisk, Inc. v. Lupin, Ltd. | Defendant | D.N.J. | 27 Jul 2023 | 18 d | Case Transferred |
| 1:23-cv-02853 | Braintree Laboratories, Inc. v. Lupin Limited | Defendant | D.N.J. | 25 May 2023 | 679 d | Case Terminated |
| 2:23-cv-02664 | Bausch & Lomb, Inc. v. Lupin Limited | Defendant | D.N.J. | 17 May 2023 | 28 d | Case Consolidated |
| 1:23-cv-00508 | Gilead Sciences, Inc. v. Lupin Limited | Defendant | D. Del. | 9 May 2023 | 651 d | Consent Judgment |
| 3:23-cv-02452 | Bausch & Lomb, Inc. v. Lupin Limited | Defendant | D.N.J. | 3 May 2023 | 97 d | Case Dismissed |
| 1:23-cv-00229 | Catalyst Pharmaceuticals, Inc. v. Lupin Limited | Defendant | D. Del. | 2 Mar 2023 | 64 d | Voluntary dismissal |
| 2:23-cv-01197 | Catalyst Pharmaceuticals, Inc. v. Lupin Limited | Defendant | D.N.J. | 1 Mar 2023 | 911 d | Consent Judgment |
| 1:23-cv-00187 | Theravance Biopharma R & D IP, LLC v. Lupin, Inc. | Defendant | D. Del. | 17 Feb 2023 | 39 d | Voluntary dismissal |
| 2:23-cv-00790 | Bausch & Lomb, Inc. v. Lupin Limited | Defendant | D.N.J. | 10 Feb 2023 | 1060 d | Closed |
| 1:23-cv-00150 | Actelion Pharmaceuticals US, Inc. v. Lupin Limited | Defendant | D. Del. | 9 Feb 2023 | 370 d | Injunction Granted |
| 2:23-cv-00094 | Merck Sharp & Dohme, LLC v. Lupin Limited | Defendant | D.N.J. | 9 Jan 2023 | 498 d | Consent Judgment |
| 1:22-cv-01465 | Amicus Therapeutics US, LLC v. Lupin Limited | Defendant | D. Del. | 7 Nov 2022 | 1141 d | Consent Judgment |
| 1:22-cv-01055 | ZS Pharma, Inc. v. Lupin Limited | Defendant | D. Del. | 10 Aug 2022 | 1043 d | Consent Judgment |
| 1:22-cv-00729 | Avion Pharmaceuticals, LLC v. Lupin Limited | Defendant | D. Del. | 2 Jun 2022 | 580 d | Dismissed without Prejudice |
| 1:22-cv-00639 | Neurocrine Biosciences, Inc. v. Lupin Limited | Defendant | D. Del. | 13 May 2022 | 549 d | Dismissed without Prejudice |
| 1:22-cv-00615 | Gilead Sciences, Inc. v. Lupin Limited | Defendant | D. Del. | 9 May 2022 | 1246 d | Consent Judgment |
| 1:21-md-03017 | Bayer AG v. Lupin Limited | Defendant | D. Del. | 10 Dec 2021 | 1510 d | Closed |
| 22-1246 | Lupin Limited v. Lundbeck, Ltd. | Plaintiff | Fed. Cir. | 10 Dec 2021 | 727 d | Appeal Dismissed |
| 1:21-cv-01710 | Galderma Laboratories v. Lupin Limited | Defendant | D. Del. | 3 Dec 2021 | 850 d | Dismissed with Prejudice |
| 22-1208 | Lupin Limited v. Lundbeck, Ltd. | Plaintiff | Fed. Cir. | 1 Dec 2021 | 736 d | Appeal Dismissed |
| 1:21-cv-01621 | Gilead Sciences, Inc. v. Lupin Limited | Defendant | D. Del. | 16 Nov 2021 | 1190 d | Consent Judgment |
| 1:21-cv-01615 | Gilead Sciences, Inc. v. Lupin Limited | Defendant | D. Del. | 15 Nov 2021 | 485 d | Consent Judgment |
| 1:21-cv-01561 | ViiV Healthcare, Co. v. Lupin Limited | Defendant | D. Del. | 2 Nov 2021 | 497 d | Consent Judgment |
| 1:21-cv-01424 | Zogenix, Inc. v. Lupin Limited | Defendant | D. Del. | 6 Oct 2021 | 763 d | Case Consolidated |
| 1:21-cv-01408 | Neurocrine Biosciences, Inc. v. Lupin Limited | Defendant | D. Del. | 1 Oct 2021 | 773 d | Dismissed without Prejudice |
| 1:21-cv-01293 | Supernus Pharmaceuticals, Inc. v. Lupin Limited | Defendant | D. Del. | 10 Sep 2021 | 794 d | Dismissed without Prejudice |
| 1:21-cv-01019 | Vertex Pharmaceuticals, Inc. v. Lupin Limited | Defendant | D. Del. | 13 Jul 2021 | 867 d | Dismissed without Prejudice |
| 1:20-cv-01155 | Intercept Pharmaceuticals, Inc. v. Lupin Limited | Defendant | D. Del. | 28 Aug 2020 | 907 d | Consent Judgment |
| 1:20-cv-00911 | Vifor Fresenius Medical Care Renal Pharma, Ltd. v. Lupin Limited | Defendant | D. Del. | 6 Jul 2020 | 945 d | Consent Judgment |
Source: Patsnap Litigation Data. Cases naming Lupin Limited in the current snapshot.
Run this in Eureka
Patsnap Eureka
See what Lupin is protecting
Portfolio, claim scope and where its coverage is thin. Every answer cites the records behind it.
Analyse this portfolio10,000 free credits to start
Lupin
Map this dispute space
- 01Ranked prior artEvery hit source-linked
- 02Claim-level comparisonAgainst your own product
- 03Legal statusAcross 174 jurisdictions
Disclaimer. This page indexes publicly available court docket data and is provided for general information and reference only. It is not legal advice and must not be relied upon as such.
Coverage has limits. Records come from a snapshot and may lag live dockets. Sealed filings, amended complaints and post-closure motions may not be reflected, and a case missing from this list is not evidence that it does not exist. Counts on this page describe what the snapshot contains, nothing more.
No characterisation of any party. Appearing on this page means a party is named in a docket record. Nothing here should be read as an assertion that any party infringed, that any patent is valid or invalid, or that any party prevailed.